MednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Neuroimmunology   

Questions discussed in this category


What treatment strategies would you utilize in a patient with newly diagnosed HLA-B27+ axial spondyloarthritis (with active and chronic sacroiliitis on MRI) and recent diagnosis of MS that is well-controlled MS ocrelizumab given the need to avoid TNF inhibitors?
Patient did not have improvement with NSAIDs. Would you consider adding IL-17 blockade? Do you consider reduced dosing schedules in the setting of dua...
1 Answer available
26635

Related Topics

  • Neurology
  • Neuro-infectious disease
  • Rheumatology
  • Spondyloarthritis
  • Multiple sclerosis

Copyright © 2026 Mednet
All Rights Reserved.